M C Suresh Babu
Overview
Explore the profile of M C Suresh Babu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sindhusha K, C Saldanha S, Abraham Jacob L, Suresh Babu M, Lokesh K, Rudresha A, et al.
Indian J Hematol Blood Transfus
. 2025 Feb;
41(1):69-74.
PMID: 39917515
No abstract available.
2.
Abraham Jacob L, Choudhary S, Suresh Babu M, K N L, Rudresha A, Rajeev L, et al.
Indian J Hematol Blood Transfus
. 2024 Oct;
40(4):588-595.
PMID: 39469170
Multiple myeloma (MM) has witnessed significant therapeutic advancements through the introduction of proteasome inhibitors and immunomodulators, leading to improved treatment outcomes. However, infections remain a formidable challenge for MM patients....
3.
Patidar Y, Saldhana S, Suresh Babu M, Abraham Jacob L, Rudresh A, Lokesh K, et al.
Lung India
. 2024 Aug;
41(5):375-378.
PMID: 39215982
Orbital metastasis is a rare entity in oncology. With increasing awareness and advancement, patients with initial ocular presentation can be diagnosed and treated. Ocular metastasis is more common in breast...
4.
Abraham Jacob L, Begum T, Halder A, Suresh Babu M, Lokesh K, Rudresha A, et al.
Indian J Hematol Blood Transfus
. 2024 Jul;
40(3):392-399.
PMID: 39011262
Hodgkin's lymphoma treatment outcomes have been the true success story of modern medicine. Various data from western as well as Indian studies are available for classical Hodgkin's lymphoma (cHL). Here...
5.
Saldanha S, Goyal S, Dasappa L, Abraham Jacob L, Suresh Babu M, Lokesh K, et al.
Int J Hematol Oncol Stem Cell Res
. 2023 Jan;
16(3):184-188.
PMID: 36694704
Multiple myeloma constitutes a wide spectrum of diseases, ranging from slow-growing monoclonal gammopathy of undetermined significance to rapidly progressing plasma cell leukemia. It is a very rarely diagnosed hematological malignancy...
6.
Rudresha A, Hassan S, Sreevalli A, Lokanatha D, Suresh Babu M, Lokesh K, et al.
J Egypt Natl Canc Inst
. 2022 May;
34(1):20.
PMID: 35527285
Context: Treatment-related toxicities in DLBCL (diffuse large B cell lymphoma) patients are higher in the initial phase of treatment (first cycle effect). Implementation of pre-phase treatment before definitive chemotherapy had...
7.
Rudresha A, Sansar B, Lokanath D, Abraham Jacob L, Suresh Babu M, Lokesh K, et al.
South Asian J Cancer
. 2021 Dec;
10(3):190-194.
PMID: 34938684
Bone marrow aspiration although being a common procedure is associated with significant pain and its reduction remains an unmet need. We evaluated the use of tramadol and eutectic mixture of...
8.
Goyal S, Abraham Jacob L, Lokanatha D, Suresh Babu M, Lokesh K, Rudresha A, et al.
Breast Dis
. 2021 Aug;
41(1):115-121.
PMID: 34420937
Background: The present era of individualized treatment for breast cancer is influenced by the initial disease status including the anatomical extent, grade, and receptor status. An accurate preoperative staging is...
9.
Rajeev L, Thottian A, Amirtham U, Lokanatha D, Abraham Jacob L, Suresh Babu M, et al.
Lung India
. 2020 Nov;
37(6):491-494.
PMID: 33154210
Introduction: Invasive mucinous adenocarcinoma (IMA) of the lung is a distinct histologic variant of adenocarcinomas comprising about 2%-10% of lung adenocarcinomas. A large proportion of IMAs carry KRAS mutations and...
10.
Lokanatha D, Hassan S, Abraham Jacob L, Suresh Babu M, Lokesh K, Rudresha A, et al.
Cancer Epidemiol
. 2020 Jun;
67:101770.
PMID: 32593160
Study Setting And Methods: A prospective analysis of patients with esophagogastric cancer presenting to a single tertiary care unit over a period of 12 months was performed. Histopathology other than...